BTB Pharma’s programme builds on a unique biomedical platform that has emerged over the last 10 years. The purpose of this platform is to bring new important therapies to the market that significantly improve the quality of life for patients suffering of any organ/tissue specific autoimmune disease or allergy.  BTB Pharma is at the beginning of fulfilling our purpose and we are currently working towards generating Proof of Concept data in pre-clinical models for a couple of diseases.